
    
      The trial is single site, double blind, randomized of HMO addition (1.5 g /day) to standard
      of care in paediatric diarrhoea patients. HMO application and follow-up of the children at
      home will be done for 2 weeks. Control patients receive only the standard of care (ORS plus
      zinc). A breastfed group of diarrhoea patients will serve as reference group.

      The total sample size is 495 patients. Patients will be females and males aged 6 months to 2
      years old with acute diarrhoea.
    
  